For more than 50 years, small airways disease has been considered a key feature of chronic obstructive pulmonary disease (COPD) and a major cause of airway obstruction. Both preventable and treatable, small airways disease has important clinical consequences if left unchecked. Small airways disease is associated with poor spirometry results, increased lung hyperinflation, and poor health status, making the small airways an important treatment target in COPD. The early detection of small airways disease remains the key barrier; if detected early, treatments designed to target small airways may help reduce symptoms and allow patients to maintain their activities. Studies are needed to evaluate the possible role of new drugs and novel drug formulations, inhalers, and inhalation devices for treating small airways disease. These developments will help to improve our management of small airways disease in patients with COPD.
Why We Should Target Small Airways Disease in Our Management of Chronic Obstructive Pulmonary Disease / Usmani, Omar S; Dhand, Rajiv; Lavorini, Federico; Price, David. - In: MAYO CLINIC PROCEEDINGS. - ISSN 0025-6196. - ELETTRONICO. - (2021), pp. 1-16. [10.1016/j.mayocp.2021.03.016]
Why We Should Target Small Airways Disease in Our Management of Chronic Obstructive Pulmonary Disease
Lavorini, FedericoMembro del Collaboration Group
;
2021
Abstract
For more than 50 years, small airways disease has been considered a key feature of chronic obstructive pulmonary disease (COPD) and a major cause of airway obstruction. Both preventable and treatable, small airways disease has important clinical consequences if left unchecked. Small airways disease is associated with poor spirometry results, increased lung hyperinflation, and poor health status, making the small airways an important treatment target in COPD. The early detection of small airways disease remains the key barrier; if detected early, treatments designed to target small airways may help reduce symptoms and allow patients to maintain their activities. Studies are needed to evaluate the possible role of new drugs and novel drug formulations, inhalers, and inhalation devices for treating small airways disease. These developments will help to improve our management of small airways disease in patients with COPD.File | Dimensione | Formato | |
---|---|---|---|
Mayo Clin Proceedings_Usmani et al. Small airways.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
3.01 MB
Formato
Adobe PDF
|
3.01 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.